Loading...
Market
Mpox vaccination rates increase by at least 50% in low-income nations by June 30, 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Reports from WHO or other health organizations
Story
WHO Allows Pre-Approval Mpox Vaccine Purchases for Low-Income Nations
Aug 23, 2024, 11:32 AM
The World Health Organization (WHO) has announced that its partners, including Gavi and UNICEF, can begin negotiations to purchase mpox vaccines before they receive official approval. This decision is aimed at facilitating the distribution of vaccines to low-income nations, ensuring they have access to necessary medical supplies. The move is part of a broader strategy to address public health needs promptly, especially in regions that may face challenges in accessing vaccines post-approval.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
0-10 countries • 25%
11-20 countries • 25%
21-30 countries • 25%
31+ countries • 25%
Yes, to one neighboring country • 25%
Yes, to two neighboring countries • 25%
Yes, to three or more neighboring countries • 25%
No • 25%
Yes • 50%
No • 50%
Highly Effective (>90% reduction) • 25%
Moderately Effective (50-90% reduction) • 25%
Slightly Effective (10-50% reduction) • 25%
Not Effective (<10% reduction) • 25%
Significant decrease in cases • 25%
Moderate decrease in cases • 25%
No change in case numbers • 25%
Increase in cases • 25%
Less than 50% • 25%
50% - 75% • 25%
75% - 90% • 25%
More than 90% • 25%